Literature DB >> 32282939

Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury.

Asmita Choudhury1, Daniel Bullock1, Arlene Lim1, Josepmaria Argemi2, Pontus Orning3,4, Egil Lien3,4, Ramon Bataller2, Pranoti Mandrekar1.   

Abstract

BACKGROUND: Activation of NLRP3 in liver macrophages contributes to alcohol-associated liver disease (ALD). Molecular chaperone heat shock protein (HSP) 90 facilitates NLRP3 inflammasome activity during infections and inflammatory diseases. We previously reported that HSP90 is induced in ALD and regulates proinflammatory cytokines, tumor necrosis factor alpha, and IL-6. Whether HSP90 affects IL-1β and IL-18 regulated by NLRP3 inflammasome in ALD is unknown. Here, we hypothesize that HSP90 modulated NLRP3 inflammasome activity and affects IL-1β and IL-18 secretion in ALD.
METHODS: The expression of HSP90AA1 and NLRP3 inflammasome genes was evaluated in human alcoholic livers and in mouse model of ALD. The importance of HSP90 on NLRP3 inflammasome activation in ALD was evaluated by administering HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) to mice subjected to ALD, and in vitro to bone marrow-derived macrophages (BMDM) stimulated with LPS and ATP. The effect of activation of HSF1/HSPA1A axis during HSP90 inhibition or direct activation during heat shock of BMDMs on NLRP3 activity and secretion of downstream cytokines was evaluated.
RESULTS: We found positive correlation between induction of HSP90 and NLRP3 inflammasome genes in human alcoholic cirrhotic livers. Administration of 17-DMAG in mouse model of ALD significantly down-regulated NLRP3 inflammasome-mediated caspase-1 (CASP-1) activity and cytokine secretion, with reduction in ALD. 17-DMAG-mediated decrease in NLRP3 was restricted to liver macrophages. Using BMDMs, we show that inhibition of HSP90 prevented CASP-1 activity, and Gasdermin D (GSDMD) cleavage, important in release of active IL-1β and IL-18. Interestingly, activation of the heat shock factor 1 (HSF1)/HSPA1A axis, either during HSP90 inhibition or by heat shock, decreased NLRP3 inflammasome activity and reduced secretion of cytokines.
CONCLUSION: Our studies indicate that inhibition of HSP90 and activation of HSF1/HSPA1A reduce IL-1β and IL-18 via decrease in NLRP3/CASP-1 and GSDMD activity in ALD.
© 2020 by the Research Society on Alcoholism.

Entities:  

Keywords:  17-DMAG; Caspase-1; Gasdermin D; HSPA1A; alcohol-associated liver disease

Mesh:

Substances:

Year:  2020        PMID: 32282939      PMCID: PMC7328660          DOI: 10.1111/acer.14338

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  32 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Heat shock inhibits caspase-1 activity while also preventing its inflammasome-mediated activation by anthrax lethal toxin.

Authors:  Tera C Levin; Katherine E Wickliffe; Stephen H Leppla; Mahtab Moayeri
Journal:  Cell Microbiol       Date:  2008-08-28       Impact factor: 3.715

3.  Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6.

Authors:  Yue Xie; Changmin Chen; Mary Ann Stevenson; Philip E Auron; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

4.  The myeloid heat shock transcription factor 1/β-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury.

Authors:  Shi Yue; Jianjun Zhu; Ming Zhang; Changyong Li; Xingliang Zhou; Min Zhou; Michael Ke; Ronald W Busuttil; Qi-Long Ying; Jerzy W Kupiec-Weglinski; Qiang Xia; Bibo Ke
Journal:  Hepatology       Date:  2016-08-29       Impact factor: 17.425

Review 5.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

6.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

Review 7.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

8.  Mouse model of chronic and binge ethanol feeding (the NIAAA model).

Authors:  Adeline Bertola; Stephanie Mathews; Sung Hwan Ki; Hua Wang; Bin Gao
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

Review 9.  Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Herbert Tilg; Alexander R Moschen; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

10.  Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.

Authors:  Amber Shatzer; Mir A Ali; Mayra Chavez; Kennichi Dowdell; Min-Jung Lee; Yusuke Tomita; Iman El-Hariry; Jane B Trepel; David A Proia; Jeffrey I Cohen
Journal:  Leuk Lymphoma       Date:  2016-08-11
View more
  10 in total

1.  HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Xueyan Shi; Tao Li; Yanting Liu; Leijin Yin; Lan Xiao; Liyao Fu; Yaxi Zhu; Huan Chen; Kangkai Wang; Xianzhong Xiao; Huali Zhang; Sichuang Tan; Sipin Tan
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  Identifying the Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treating Acute Liver Failure Based on Network Pharmacology and Molecular Docking.

Authors:  Jing Hong; Jie Ding; Han-Han Hong; Xiao-Wan Xu; Bo Pan; Yi Ruan; Xiao-Feng Zhai
Journal:  Gastroenterol Res Pract       Date:  2022-04-08       Impact factor: 1.919

Review 3.  The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

Authors:  Brendan Le Daré; Pierre-Jean Ferron; Thomas Gicquel
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

4.  Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin-1β-dependent inflammation.

Authors:  Yaoyao Xia; Qingzhuo Zhang; Yuyi Ye; Xiaoyan Wu; Fang He; Yuanyi Peng; Yulong Yin; Wenkai Ren
Journal:  Clin Transl Med       Date:  2022-02

5.  Loss of heat shock factor 1 promotes hepatic stellate cell activation and drives liver fibrosis.

Authors:  Asmita Choudhury; Anuradha Ratna; Arlene Lim; Rebecca M Sebastian; Christopher L Moore; Aveline A Filliol; Jacob Bledsoe; Chengkai Dai; Robert F Schwabe; Matthew D Shoulders; Pranoti Mandrekar
Journal:  Hepatol Commun       Date:  2022-08-09

6.  Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology.

Authors:  Rui Qiang; Ya Zhang; Yanhong Wang
Journal:  Dis Markers       Date:  2022-10-04       Impact factor: 3.464

Review 7.  Molecular Chaperones: Molecular Assembly Line Brings Metabolism and Immunity in Shape.

Authors:  Haoxin Zhao; Lydia N Raines; Stanley Ching-Cheng Huang
Journal:  Metabolites       Date:  2020-10-03

8.  Protective effect of Aster tataricus extract on NLRP3-mediated pyroptosis of bladder urothelial cells.

Authors:  Xin Wang; Ling Fan; Hao Yin; Yiqun Zhou; Xiaolong Tang; Xiaojun Fei; Hailin Tang; Juan Peng; Xiaoqin Ren; Yi Xue; Chunli Zhu; Jianping Luo; Qinglei Jin; Qingjiang Jin
Journal:  J Cell Mol Med       Date:  2020-10-08       Impact factor: 5.295

9.  Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.

Authors:  Sohaib Nizami; Kanisa Arunasalam; Jack Green; James Cook; Catherine B Lawrence; Tryfon Zarganes-Tzitzikas; John B Davis; Elena Di Daniel; David Brough
Journal:  Immunology       Date:  2020-10-30       Impact factor: 7.397

10.  Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease.

Authors:  Anuradha Ratna; Arlene Lim; Zihai Li; Josepmaria Argemi; Ramon Bataller; Gabriela Chiosis; Pranoti Mandrekar
Journal:  Hepatol Commun       Date:  2021-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.